Patrick M. McCarthy

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Alexandra M. Adams · 4 shared papers, 2021–2024 · strength 0.62
   • Paper The benefit of adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic adenocarcinoma depends on respons… DOI 10.1002/jso.27689↗
   • Paper Predictors and benefits of multiagent chemotherapy for pancreatic adenocarcinoma: Timing matters. DOI 10.1002/jso.27466↗
   • Paper Downstaging of Pancreatic Adenocarcinoma With Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves Survival. DOI 10.1245/s10434-022-11800-0↗
2. Anne E. O’Shea · 4 shared papers, 2021–2024 · strength 0.62
   • Paper The benefit of adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic adenocarcinoma depends on respons… DOI 10.1002/jso.27689↗
   • Paper Predictors and benefits of multiagent chemotherapy for pancreatic adenocarcinoma: Timing matters. DOI 10.1002/jso.27466↗
   • Paper Downstaging of Pancreatic Adenocarcinoma With Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves Survival. DOI 10.1245/s10434-022-11800-0↗
3. Daniel William Nelson · 4 shared papers, 2021–2024 · strength 0.62
   • Paper The benefit of adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic adenocarcinoma depends on respons… DOI 10.1002/jso.27689↗
   • Paper Predictors and benefits of multiagent chemotherapy for pancreatic adenocarcinoma: Timing matters. DOI 10.1002/jso.27466↗
   • Paper Downstaging of Pancreatic Adenocarcinoma With Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves Survival. DOI 10.1245/s10434-022-11800-0↗
4. Timothy J. Vreeland · 4 shared papers, 2021–2024 · strength 0.62
   • Paper The benefit of adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic adenocarcinoma depends on respons… DOI 10.1002/jso.27689↗
   • Paper Predictors and benefits of multiagent chemotherapy for pancreatic adenocarcinoma: Timing matters. DOI 10.1002/jso.27466↗
   • Paper Downstaging of Pancreatic Adenocarcinoma With Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves Survival. DOI 10.1245/s10434-022-11800-0↗
5. Elizabeth L. Carpenter · 3 shared papers, 2022–2024 · strength 0.50
   • Paper The benefit of adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic adenocarcinoma depends on respons… DOI 10.1002/jso.27689↗
   • Paper Predictors and benefits of multiagent chemotherapy for pancreatic adenocarcinoma: Timing matters. DOI 10.1002/jso.27466↗
   • Paper Downstaging of Pancreatic Adenocarcinoma With Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves Survival. DOI 10.1245/s10434-022-11800-0↗
6. Franklin A. Valdera · 2 shared papers, 2024 · strength 0.36
   • Paper The benefit of adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic adenocarcinoma depends on respons… DOI 10.1002/jso.27689↗
   • Paper Predictors and benefits of multiagent chemotherapy for pancreatic adenocarcinoma: Timing matters. DOI 10.1002/jso.27466↗
7. Robert Connor Chick · 2 shared papers, 2022–2024 · strength 0.31
   • Paper Predictors and benefits of multiagent chemotherapy for pancreatic adenocarcinoma: Timing matters. DOI 10.1002/jso.27466↗
   • Paper Downstaging of Pancreatic Adenocarcinoma With Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves Survival. DOI 10.1245/s10434-022-11800-0↗
8. Phillip M. Kemp Bohan · 2 shared papers, 2022–2024 · strength 0.31
   • Paper Predictors and benefits of multiagent chemotherapy for pancreatic adenocarcinoma: Timing matters. DOI 10.1002/jso.27466↗
   • Paper Downstaging of Pancreatic Adenocarcinoma With Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves Survival. DOI 10.1245/s10434-022-11800-0↗
9. Robert W. Krell · 2 shared papers, 2021–2022 · strength 0.26
   • Paper Downstaging of Pancreatic Adenocarcinoma With Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves Survival. DOI 10.1245/s10434-022-11800-0↗
   • Paper Near Complete Pathologic Response to PD-1 Inhibitor and Radiotherapy in a Patient with Locally Advanced Pancreatic Duct… DOI 10.2147/ott.s311661↗
10. Timothy Eric Newhook · 1 shared paper, 2024 · strength 0.19
    • Paper The benefit of adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic adenocarcinoma depends on respons… DOI 10.1002/jso.27689↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.